An Efficient Method for the Large-Scale Synthesis of Atorvastatin Calcium
![]() ![]() |
Lee, Hong-Woo
(Chemical Process Research and Development Laboratory, Chemical Research Group, Chong Kun Dang Research Institute)
Kim, Young-Min (Chemical Process Research and Development Laboratory, Chemical Research Group, Chong Kun Dang Research Institute) Yoo, Choong-Leol (Chemical Process Research and Development Laboratory, Chemical Research Group, Chong Kun Dang Research Institute) Kang, Sung-Kwon (Chemical Process Research and Development Laboratory, Chemical Research Group, Chong Kun Dang Research Institute) Ahn, Soon-Kil (Chemical Process Research and Development Laboratory, Chemical Research Group, Chong Kun Dang Research Institute) |
1 | Baumann, K. L., Butler, D. E., Deering, C. F., Mennen, K. E., Millar, A., Nanninga, T. N., Palmer, C. W., and Roth, B. D. (1992). The convergent synthesis of CI-981, an optically active, highly potent, tissue selective inhibitor of HMG-CoA reductase. Tetrahedron Lett. 33, 2283-2284 DOI ScienceOn |
2 | Brazil, M. (2002). A new use for statins? Nature Reviews Drug Discovery 1, 934 DOI |
3 | Brower, P. L., Butler, D. E., Deering, C. F., Le, T. V., Millar, A., Nanninga, T. N., and Roth, B. D. (1992). The synthesis of (4R-cis)-1,1-dimethylethyl-6-cyanomethyl-2,2-dimethyl- 1,3-dioxane-4-acetate, a key intermediate for the preparation of CI-981, a highly potent, tissue selective inhibitor of HMG-CoA reductase. Tetrahedron Lett. 33, 2279-2282 DOI ScienceOn |
4 | Butler, D. E., Deering, C. F., Millar, A., Nanninga, T. N., and Roth, B. D. (1989). Improved process for trans-6-[2-(substituted- pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis. W.O. Patent 89/07598 |
5 |
Moore, R. N., Bigam, G., Chan, J. K., Hogg, A. M., Nakashima, T. T., and Vederas, J. C. (1985). Biosynthesis of the hypocholesterolemic agent mevinolin by Aspergillus terreus. Determination of the origin of carbon, hydrogen, and oxygen atoms by |
6 | Srinath, S., Mathew, J., Ujire, S., Sridharan, M., and Sambasivam, G. (2002). Process for the atorvastatin form V and phenylboronates as intermediate compounds. W.O. Patent 02/057274 |
7 | Park, W. K. C., Kennedy, R. M., Larsen, S. D., Miller, S., Roth, B. D., Song, Y., Steinbaugh, B. A., Sun, K., Tait, B. D., Kowala, M. C., Trivedi, B. K., Auerbach, B., Askew, V., Dillon, L., Hanselman, J. C., Lin, Z., Lu, G. H., Robertson, A., and Sekerke, C. (2008). Hepatoselectivity of statins: Design and synthesis of 4-sulfamoylpyrroles as HMG-CoA reductase inhibitors. Bioorg. Med. Chem. Lett. 18, 1151-1156 DOI ScienceOn |
8 | Roth, B. D., and Mich, A. A. (1987). Trans-6-[2-(3- or 4-carboxamido- substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis. U.S. Patent 4,681,893 |
9 | Roth, B. D., Sliskovic, D. R., and Trivedi, B. K. (1989). Treatment of hypercholesterolemia. Annu. Rep. Med. Chem. 24, 147-156 DOI |
10 |
Wade, R. A., Zennie, T. M., Briggs, C. A., Jennings, R. A., Nanninga, T. N., Palmer, C. W., and Ronald, J. C. (1997). In pursuit of higher purity: Use of |
11 | Butler, D. E., Dejong, R. L., Nelson, J. D., Pamment, M. G., and Stuk, T. L. (2002). Novel Process for the synthesis of 5-(4-Fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydropyran- 2-yl)ethyl]-2-isopropyl-4-phenyl-1H-pyrrole- 3-carboxylic acid phenylamide. W.O. Patent 02/055519 |
12 | Graul, A., and Castaner, J. (1997). Atorvastatin calcium. Drugs Future. 22, 956-968 DOI |
13 | Kathawala, F. G. (1991). HMG-CoA reductase inhibitors: An exciting development in the treatment of hyperlipoproteinemia. Med. Res. Rev. 11, 121-146 |
14 | Moody, D. J., and Wiffen, J. W. (2005). Process and intermediate compound useful in the preparation of statins, particularly atorvastatin. W.O. Patent 05/012246 |
15 | Sattigeri, J. A., Salman, M., Rawat, S., and Sethi, S. (2005). Process for the preparation of atorvastatin. W.O. Patent 05/118536 |
16 | Roth, B. D., Blankley, C. J., Chucholowski, A. W., Ferguson, E., Hoefle, M. L., Ortwine, D. F., Newton, R. S., Sekerke, C. S., Sliskovic, D. R., Stratton, C. D., and Wilson, M. W. (1991). Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran- 2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus. J. Med. Chem. 34, 357-366 DOI |
17 |
Roth, B. D., and Mich, A. A. (1993). [R-(R*,R*)]-2-(4-Fluorophenyl)- |
![]() |